These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 7927946)

  • 1. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
    Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
    Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
    Mineta H; Borg A; Dictor M; Wahlberg P; Wennerberg J
    Oral Oncol; 1997 Jan; 33(1):42-6. PubMed ID: 9192552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.
    el-Naggar AK; Steck K; Batsakis JG
    Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma.
    Davidson BJ; Lydiatt WM; Abate MP; Schantz SP; Chaganti RS
    Head Neck; 1996; 18(6):512-21. PubMed ID: 8902564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
    Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP
    Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma.
    Callender T; el-Naggar AK; Lee MS; Frankenthaler R; Luna MA; Batsakis JG
    Cancer; 1994 Jul; 74(1):152-8. PubMed ID: 8004570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
    Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
    Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inactivation of p53 and amplification of cyclin D1 in squamous cell carcinomas of the head and neck].
    Rodrigo Tapia JP; González Meana MV; García González LA; Coto E; García Pedrero J; Núñez Batalla F; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2002 Apr; 53(4):225-32. PubMed ID: 12185899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CCND1 oncogene amplification and cellular DNA content in squamous cell carcinomas of the head and neck].
    Rodrigo Tapia JP; García González LA; Martínez Sánchez JA; González Meana MV; García Pedrero JM; Suárez Nieto C
    Acta Otorrinolaringol Esp; 2001 Oct; 52(7):539-43. PubMed ID: 11692945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
    Xu L; Chen YT; Huvos AG; Zlotolow IM; Rettig WJ; Old LJ; Garin-Chesa P
    Diagn Mol Pathol; 1994 Jun; 3(2):83-92. PubMed ID: 8061893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection.
    Eicheler W; Zips D; Dörfler A; Grénman R; Baumann M
    J Histochem Cytochem; 2002 Feb; 50(2):197-204. PubMed ID: 11799138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
    Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
    Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
    Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
    Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
    Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
    Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma.
    Kyomoto R; Kumazawa H; Toda Y; Sakaida N; Okamura A; Iwanaga M; Shintaku M; Yamashita T; Hiai H; Fukumoto M
    Int J Cancer; 1997 Dec; 74(6):576-81. PubMed ID: 9421351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities.
    Ruggeri BA; Bauer B; Zhang SY; Klein-Szanto AJ
    Carcinogenesis; 1994 Aug; 15(8):1613-9. PubMed ID: 8055640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
    Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.